Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(18 sites)
Spain
Hospital Universitario de Álava, Alava Hospital Universitario de Cruces, Barakaldo Hospital Universitario Vall d'Hebron, Barcelona Hospital Clínico de Barcelona, Barcelona Hospital Universitario de Donostia, Donostia / San Sebastian Hospital Universitario Virgen de las Nieves, Granada Hospital San Pedro, Logroño Hospital Universitario Gregorio Marañón, Madrid Hospital Clínico San Carlos, Madrid Hospital Universitario La Paz, Madrid Hospital Universitario Puerta del Hierro, Madrid Hospital Universitario Regional de Málaga, Málaga Hospital Universitario Virgen de la Victoria, Málaga Hospital Universitario de Canarias, San Cristóbal de La Laguna Hospital Universitario Marqués de Valdecilla, Santander Hospital Universitario Virgen Macarena, Seville Hospital Universitario Virgen del Rocío, Seville Hospital Universitari MútuaTerrassa, Terrassa